Therapy (HBV)
Treating Healthy HBsAg Carriers Could Activate Liver Disease
Published in Hepatitis Weekly, November 10th, 1997
Researchers concluded that interferon treatment should not be given to hepatitis B surface antigen healthy carriers with normal alanine aminotransferase, regardless of the presence of chronic hepatitis or serum DNA.
There are two distinct phases of chronic hepatitis B virus (HBV) infection. In the first years of the infection, high replication levels of HBV are detected, with serum hepatitis B e antigen (HBeAg) and HBV DNA and a progressive liver disease. Either spontaneously, in about 25 percent of patients per...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (1997-11-10)
More Articles from Hepatitis Weekly
- Outbreak (HAV)
Needle-Sharing May Have Caused Hepatitis A Outbreak - Acute Renal Failure
Relief Efforts In ARF Epidemic: The Haiti Experience - Conference Coverage (ICAAC)
CDC: Adverse Events After Vaccination Declining - HIV Testing
Registration For New HIV 1+2+0 Screening Test Granted in France - Immunization
Flu Shot Recipients Worried About AIDS - Immunization (Adverse Effects)
Timing of Pediatric Vaccines Possibly Linked to Development of Type 1 Diabetes - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
